AARTIDRUGS
₹374.65-0.25 (-0.07%)
Quarterly ResultsProfit & LossBalance SheetCash Flow
Key Insights
POSITIVE
- Record high net sales in the latest quarter indicate strong demand for products.
- Improved operating margin in the latest quarter shows better cost management and operational efficiency.
- Noticeable growth in net profit in the latest quarter suggests effective financial strategies.
NEGATIVE
- Company experienced a cash flow shortfall with a 10% decrease this year [Dummy Data]
- Company’s strategic partnerships have yet to generate expected growth. [Dummy Data]
- Company’s EBITDA shrank at a CAGR of -8% over the past 3 years. [Dummy Data]
Quarterly Results Data
| Field | Trend | Mar 24 | Jun 24 | Sep 24 | Dec 24 | Mar 25 | Jun 25 | Sep 25 | Dec 25 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 619.99 | 555.34 | 598.33 | 556.60 | 676.76 | 590.51 | 652.79 | 601.71 | |
| Expenses | 556.89 | 512.47 | 553.93 | 517.74 | 607.48 | 539.71 | 592.47 | 573.91 | |
| Operating Profit | 63.10 | 42.87 | 44.40 | 38.86 | 69.28 | 50.80 | 60.32 | 27.80 | |
| Other Income | 1.08 | 1.11 | 1.48 | 11.90 | 1.87 | 0.31 | 0.09 | 1.23 | |
| Interest | 9.13 | 8.71 | 8.93 | 9.07 | 9.16 | 8.56 | 7.70 | 9.29 | |
| Depreciation | 13.58 | 13.38 | 13.72 | 13.80 | 14.88 | 14.72 | 16.26 | 17.95 | |
| Profit Before Tax | 64.18 | 43.98 | 45.88 | 50.76 | 71.15 | 51.11 | 60.41 | 29.03 | |
| Tax | 16.87 | 10.71 | 10.92 | 13.67 | 8.38 | -2.86 | 15.25 | -11.52 | |
| Net Profit | 47.31 | 33.27 | 34.96 | 37.09 | 62.77 | 53.97 | 45.16 | 40.55 | |
| EPS in Rs | 5.15 | 3.62 | 3.83 | 4.06 | 6.88 | 5.91 | 4.95 | 4.44 |